Delphia Therapeutics
Latest round
- Series A
Last raised
- May 2024
Total raised
- $67M
Investors
- 4
About Delphia Therapeutics
Founded in 2022 and based in Massachusetts, US, Delphia Therapeutics, Inc. operates as a biotechnology company that develops therapeutics for cancer treatment. In May 2024, Delphia Therapeutics, Inc. The firm offers therapies that charge activation lethality, that exploits cancer's vulnerability to oncogene overactivation to provide cancer treatment. The firm offers therapies and novel medicines that address the challenge of drug resistance commonly seen with traditional targeted therapies.
Who invested in Delphia Therapeutics
4 investors across 1 round
See all investors in Delphia Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 3, 2024
Amount
$67M
Investors
Questions about Delphia Therapeutics
Who invested in Delphia Therapeutics?
Delphia Therapeutics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Delphia Therapeutics raised?
Delphia Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Delphia Therapeutics last raise money?
Delphia Therapeutics's most recent round on record is a Series A, in May 2024.
What does Delphia Therapeutics do?
Founded in 2022 and based in Massachusetts, US, Delphia Therapeutics, Inc.
Where is Delphia Therapeutics headquartered?
Delphia Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Delphia Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Delphia Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Delphia Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.